These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7994617)

  • 1. A catalytic antibody isomerizing a delta 5-3-cétostéroïde.
    Khettal B; de Lauzon S; Desfosses B; Ushida S; Marquet A
    C R Acad Sci III; 1994 May; 317(5):381-5. PubMed ID: 7994617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of covalent binding antibodies.
    Armentano F; Knight T; Makker S; Tramontano A
    Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and fluorescence studies of affinity maturation in related antibodies.
    Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
    Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A competitive immunoassay for the detection of esterolytic activity of antibodies and enzymes.
    Benedetti F; Berti F; Flego M; Resmini M; Bastiani E
    Anal Biochem; 1998 Feb; 256(1):67-73. PubMed ID: 9466799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic polyclonal antibodies.
    Stephens DB; Iverson BL
    Biochem Biophys Res Commun; 1993 May; 192(3):1439-44. PubMed ID: 8507208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant.
    Mitsuda Y; Hifumi E; Tsuruhata K; Fujinami H; Yamamoto N; Uda T
    Biotechnol Bioeng; 2004 Apr; 86(2):217-25. PubMed ID: 15052642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selenium-containing catalytic antibody with Type I deiodinase activity.
    Lian G; Ding L; Chen M; Liu L; Zhao D; Ni J
    Biochem Biophys Res Commun; 2001 May; 283(5):1007-12. PubMed ID: 11355872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and characterization of lipase abzyme from phage displayed antibody libraries.
    Leong MK; Chen C; Shar KC; Shiuan D
    Biochem Biophys Res Commun; 2007 Sep; 361(3):567-73. PubMed ID: 17673171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A catalytic antibody against a tocopherol cyclase inhibitor.
    Manetsch R; Zheng L; Reymond MT; Woggon WD; Reymond JL
    Chemistry; 2004 May; 10(10):2487-506. PubMed ID: 15146522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new monoclonal anti-idiotypic catalytic antibody with a CPA-like activity.
    Du M; Guo Z; Jin S
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1487-92. PubMed ID: 10386922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure.
    Cashman JR; Berkman CE; Underiner GE
    J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivalase catalytic antibodies: towards abzymatic activation of prodrugs.
    Bensel N; Reymond MT; Reymond JL
    Chemistry; 2001 Nov; 7(21):4604-12. PubMed ID: 11757652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoabzymes: structurally and mechanistically similar catalytic antibodies from the same immunization.
    Angeles TS; Smith RG; Darsley MJ; Sugasawara R; Sanchez RI; Kenten J; Schultz PG; Martin MT
    Biochemistry; 1993 Nov; 32(45):12128-35. PubMed ID: 8218291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational and inhibitory analysis of a catalytic antibody. Implication for drug discovery.
    Phichith D; Bun S; Padiolleau-Lefèvre S; Banh S; Thomas D; Friboulet A; Avalle B
    Mol Immunol; 2009 Dec; 47(2-3):348-56. PubMed ID: 19828199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal antibody catalytic variability.
    Stephens DB; Thomas RE; Stanton JF; Iverson BL
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):127-34. PubMed ID: 9576860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic antibodies induced by a zwitterionic hapten.
    Tsumuraya T; Takazawa N; Tsunakawa A; Fleck R; Masamune S
    Chemistry; 2001 Sep; 7(17):3748-55. PubMed ID: 11575776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.